Suvretta Capital Management, LLC 89bio, Inc. Transaction History
Suvretta Capital Management, LLC
- $2.28 Billion
- Q1 2025
A detailed history of Suvretta Capital Management, LLC transactions in 89bio, Inc. stock. As of the latest transaction made, Suvretta Capital Management, LLC holds 14,335,244 shares of ETNB stock, worth $144 Million. This represents 4.56% of its overall portfolio holdings.
Number of Shares
14,335,244
Previous 10,202,696
40.5%
Holding current value
$144 Million
Previous $78.3 Million
33.18%
% of portfolio
4.56%
Previous 3.26%
Shares
9 transactions
Others Institutions Holding ETNB
# of Institutions
209Shares Held
160MCall Options Held
366KPut Options Held
944K-
Janus Henderson Group PLC London, X020.5MShares$205 Million0.09% of portfolio
-
Ra Capital Management, L.P. Boston, MA19.9MShares$199 Million3.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT9.32MShares$93.4 Million2.37% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.16MShares$71.9 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.02MShares$70.4 Million0.0% of portfolio
About 89bio, Inc.
- Ticker ETNB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,484,500
- Market Cap $466M
- Description
- 89bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its lead product candidate is pegozafermin, a glycoPEGylated analog of fibroblast growth factor 21 for the treatment of nonalcoholic steatohepatitis. The company also int...